Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ed Clarke

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
NPJ Vaccines|February 21, 2026
Plasmablast, memory B cell and T follicular helper cell responses after human papillomavirus vaccination: effect of dose number and ageEunice W Kiamba, Dolapo O Ajiboye, Adedapo Olufemi Bashorun, et al.
Trials|September 14, 2022
Study protocol for a phase 1/2, single-centre, double-blind, double-dummy, randomized, active-controlled, age de-escalation trial to assess the safety, tolerability and immunogenicity of a measles and rubella vaccine delivered by a microneedle patch in healthy adults (18 to 40 years), measles and rubella vaccine-primed toddlers (15 to 18 months) and measles and rubella vaccine-naïve infants (9 to 10 months) in The Gambia [Measles and Rubella Vaccine Microneedle Patch Phase 1/2 Age De-escalation Trial]Ikechukwu Adigweme, Edem Akpalu, Mohammed Yisa, et al.
The Pediatric Infectious Disease Journal|May 27, 2020
Viral Etiology, Clinical Features and Antibiotic Use in Children <5 Years of Age in the Gambia Presenting With Influenza-like IllnessSheikh Jarju, Khristianne Greenhalgh, Miriam Wathuo, et al.
The Lancet. Respiratory Medicine|June 26, 2019
Effect of a Russian-backbone live-attenuated influenza vaccine with an updated pandemic H1N1 strain on shedding and immunogenicity among children in The Gambia: an open-label, observational, phase 4 studyBenjamin B Lindsey, Ya Jankey Jagne, Edwin P Armitage, et al.
Trials|September 2, 2024
Collecting and reporting adverse events in low-income settings-perspectives from vaccine trials in the GambiaAndrew Ayi-Ashong Bruce, Ama-Onyebuchi Umesi, Adedapo Bashorun, et al.
The Lancet. Global Health|December 24, 2021
Intradermal administration of fractional doses of the inactivated poliovirus vaccine in a campaign: a pragmatic, open-label, non-inferiority trial in The GambiaAdedapo O Bashorun, Mariama Badjie Hydara, Ikechukwu Adigweme, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2017
The Immunogenicity of Fractional Intradermal Doses of the Inactivated Poliovirus Vaccine Is Associated With the Size of the Intradermal Fluid BlebJack Bibby, Yauba Saidu, Ama Umesi, et al.
BMJ Global Health|June 18, 2021
Establishing and operating a 'virtual ward' system to provide care for patients with COVID-19 at home: experience from The GambiaOghenebrume Wariri, Uduak Okomo, Carla Cerami, et al.
The Lancet. Microbe|December 9, 2021
The effect of live attenuated influenza vaccine on pneumococcal colonisation densities among children aged 24-59 months in The Gambia: a phase 4, open label, randomised, controlled trialChikondi Peno, Edwin P Armitage, Melanie Clerc, et al.
Plos One|September 22, 2025
Human papillomavirus, sexually transmitted infections, and antimicrobial resistance in West Africa: Estimating population burden and understanding exposures to accelerate vaccine impact and drive new interventions: The PHASE survey protocolAdedapo Olufemi Bashorun, Larry Kotei, Abdoulie F Jallow, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
NPJ Vaccines|February 21, 2026
Plasmablast, memory B cell and T follicular helper cell responses after human papillomavirus vaccination: effect of dose number and ageEunice W Kiamba, Dolapo O Ajiboye, Adedapo Olufemi Bashorun, et al.
Trials|September 14, 2022
Study protocol for a phase 1/2, single-centre, double-blind, double-dummy, randomized, active-controlled, age de-escalation trial to assess the safety, tolerability and immunogenicity of a measles and rubella vaccine delivered by a microneedle patch in healthy adults (18 to 40 years), measles and rubella vaccine-primed toddlers (15 to 18 months) and measles and rubella vaccine-naïve infants (9 to 10 months) in The Gambia [Measles and Rubella Vaccine Microneedle Patch Phase 1/2 Age De-escalation Trial]Ikechukwu Adigweme, Edem Akpalu, Mohammed Yisa, et al.
The Pediatric Infectious Disease Journal|May 27, 2020
Viral Etiology, Clinical Features and Antibiotic Use in Children <5 Years of Age in the Gambia Presenting With Influenza-like IllnessSheikh Jarju, Khristianne Greenhalgh, Miriam Wathuo, et al.
The Lancet. Respiratory Medicine|June 26, 2019
Effect of a Russian-backbone live-attenuated influenza vaccine with an updated pandemic H1N1 strain on shedding and immunogenicity among children in The Gambia: an open-label, observational, phase 4 studyBenjamin B Lindsey, Ya Jankey Jagne, Edwin P Armitage, et al.
Trials|September 2, 2024
Collecting and reporting adverse events in low-income settings-perspectives from vaccine trials in the GambiaAndrew Ayi-Ashong Bruce, Ama-Onyebuchi Umesi, Adedapo Bashorun, et al.
The Lancet. Global Health|December 24, 2021
Intradermal administration of fractional doses of the inactivated poliovirus vaccine in a campaign: a pragmatic, open-label, non-inferiority trial in The GambiaAdedapo O Bashorun, Mariama Badjie Hydara, Ikechukwu Adigweme, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2017
The Immunogenicity of Fractional Intradermal Doses of the Inactivated Poliovirus Vaccine Is Associated With the Size of the Intradermal Fluid BlebJack Bibby, Yauba Saidu, Ama Umesi, et al.
BMJ Global Health|June 18, 2021
Establishing and operating a 'virtual ward' system to provide care for patients with COVID-19 at home: experience from The GambiaOghenebrume Wariri, Uduak Okomo, Carla Cerami, et al.
The Lancet. Microbe|December 9, 2021
The effect of live attenuated influenza vaccine on pneumococcal colonisation densities among children aged 24-59 months in The Gambia: a phase 4, open label, randomised, controlled trialChikondi Peno, Edwin P Armitage, Melanie Clerc, et al.
Plos One|September 22, 2025
Human papillomavirus, sexually transmitted infections, and antimicrobial resistance in West Africa: Estimating population burden and understanding exposures to accelerate vaccine impact and drive new interventions: The PHASE survey protocolAdedapo Olufemi Bashorun, Larry Kotei, Abdoulie F Jallow, et al.
Pageof 6